Skip to Main Content

Paper Details

De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report.
Nat Commun
145
2022
Author NameAffiliation
Pavitra RoychoudhuryUniversity of Washington School of Medicine
Peiwen LuYale University School of Medicine
John FournierYale University School of Medicine
Elsio A WunderYale School of Public Health
Brett D LindenbachYale School of Medicine
Anna Marie PyleYale University
Anna Marie PyleYale University
Anna Marie PyleHoward Hughes Medical Institute
Craig B WilenYale University School of Medicine
Craig B WilenYale School of Medicine
Onyema OgbuaguYale University School of Medicine
Alexander L GreningerUniversity of Washington School of Medicine
Alexander L GreningerFred Hutchinson Cancer Research Center
Akiko IwasakiYale University School of Medicine
Akiko IwasakiYale School of Public Health
Akiko IwasakiYale University
Akiko IwasakiHoward Hughes Medical Institute
Wade Schulz (CM4AI)Center for Outcomes Research and Evaluation, Yale New Haven Hospital
Wade Schulz (CM4AI)Yale School of Medicine
Albert I KoYale University School of Medicine
Albert I KoYale School of Public Health
  • 1 - 21

Datasets

Release 1.2